Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -6.40 -12.7% 44.00 47.90 48.00 52.00 47.90 50.60 760,179 16:46:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -2.9 -1.0 - 113

Futura Medical Share Discussion Threads

Showing 20851 to 20864 of 21575 messages
Chat Pages: Latest  839  838  837  836  835  834  833  832  831  830  829  828  Older
DateSubjectAuthorDiscuss
10/4/2021
12:32
As you said yourself on here before t0pgrader - 14 Jul 2015 - 07:34:06 - 11255 of 11524 Strange that there's no mention of performance vs currently marketed products which is commercially the more important result than vs placebo.
lbo
10/4/2021
08:27
Stop writing nonsense. MED3000 Does not operate like a placebo. It was the fault of the profoundly useless BoD to employ it as such (rather than as a Control) in the P3 trial even though they had failed beforehand to establish its clinical profile.
t0pgrader
09/4/2021
11:30
Happy days! DX can have exclusive licensing rights. Please stop posting products that are similar by larger company's LBO it's misleading. Your argument is the equivalent of BMW saying they are not going to build cars anymore because that idea has been taken by GM Motors! Or Nokia saying Bluetooth is a waste of time because you can connect using WiFi.
trader00100
08/4/2021
18:32
dgdg1 You are absolutely right.
j777j
08/4/2021
16:33
Trying to patent a placebo effect to treat psychological causes of ED is the only novel part of MED3000. Will be interesting to see how consumers feel being told they are only being given a warming gel to rub on as their problem is psychological. Again the worry like with Sildenafil OTC is could MED3000 even being just approved as a Medical device therapy lead to confusion and delays in seeking a physicians help and the diagnosis of ED due to serious underlying organic diseases. https://www.futuramedical.com/what-we-do/our-technology/ Aside from our current patent lawyers, Futura recently retained a specialist biotech IP and strategic advice company to assist in maximising the robustness of the MED3000 intellectual property.
lbo
08/4/2021
16:07
Zero relevance again
dgdg1
08/4/2021
13:47
Integrity of human epidermal membranes is of zero relevance to efficacy
dgdg1
08/4/2021
12:08
Wow, LBO still talking nonsense after 3 weeks in a row, of 14 hours a days talking on ADVFN... Must be in a seriously bad open short position. I'm expecting fireworks here.
albert arthur
08/4/2021
11:31
Vicks made at least $24 million in today's money in one year. (1912) keeping in mind population, manufacturing etc.How do they make so much money with menthol Vaseline? It's just minty petroleum jelly...... strange.
trader00100
08/4/2021
11:29
Key word is "works". In the company's announcement of 12.12.19 he also said "The efficacy of the DermaSys® product is remarkable and approaches the efficacy of current first line therapy but with significantly lower adverse events. With topical application, it will be of particular appeal to patients who want a fast onset of action. Lack of drug interactions with prescription products will enable the product to be used with other medications such as nitrates and other cardiovascular drugs. It can also be used in conjunction with other ED products to improve overall efficacy to patients. As such the product will be of great interest to the medical community."
dgdg1
08/4/2021
11:25
1 word, VICKSYou're welcome ;)
trader00100
08/4/2021
10:56
The only one struggling is you, the Trinity note and the company website are perfectly clear.
dgdg1
08/4/2021
10:54
Have you never used alcohol gel on your hands? https://indianapublicmedia.org/amomentofscience/temperature-rubbing-alcohol.php https://www.scientificamerican.com/article/chilling-science-evaporative-cooling-with-liquids/ But the end result they are claiming is still physical stimulation with rubbing the gel on and warming. None of this is new. Even Trinity struggled in their research note: ‘The initial response to such a cooling would be a vasoconstriction, with reduced blood flows. However, the contrasting warming phase is then associated with a rebound vasodilation, that leads to relaxation of the smooth muscles and marked increase in local blood flows, with a resultant erection. Presumably the effect is comparable to the cold-induced vasodilation (CIVD) that occurs with extremities such as toes and fingers. Despite being a well-known effect, the mechanisms of CIVD are still disputed, but the pathways involved could well be similar. Interestingly, the precise mechanism of action does not need to be elucidated for the regulators to be comfortable for a product to be approved as medical device’
lbo
08/4/2021
10:17
Please read the company website about the only physical mode of action. Someone in the company must have got the idea from the movie American Pie! Good luck with getting the patent!!! lol https://www.looper.com/308052/the-truth-about-jason-biggs-warm-apple-pie-scene/ https://www.futuramedical.com/what-we-do/med3000/med3000-clinical-programme/ ‘physical sensations, including touch, pressure and temperature’
lbo
Chat Pages: Latest  839  838  837  836  835  834  833  832  831  830  829  828  Older
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210516 06:54:49